PHIO (Phio Pharmaceuticals Corp.) Stock Financials & Earnings | Market Cap Arena

PHIO (Phio Pharmaceuticals Corp.) Stock Financials & Earnings | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

Mkt Cap$13M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$9M

EPS (TTM)-$41071.24

Free Cash Flow (TTM)-$8M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Next: Q1 2026 · Mar 25

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	-$2M	-$4M
Q2 23	$0	-$49K	-$3M
Q3 23	$0	-$2M	-$3M
Q4 23	$0	-$43K	-$2M
Q1 24	$0	$0	-$2M
Q2 24	$0	-$866K	-$2M
Q3 24	$0	-$644K	-$2M
Q4 24	$0	$0	-$2M
Q1 25	$0	$0	-$2M
Q2 25	$0	-$1M	-$2M
Q3 25	$0	-$2K	-$3M
Q4 25	$0	-$1K	-$3M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$3M	-$3M
Q2 23	-$3M	-$3M
Q3 23	-$3M	-$3M
Q4 23	-$2M	-$2M
Q1 24	-$2M	-$2M
Q2 24	-$2M	-$2M
Q3 24	-$2M	-$2M
Q4 24	-$1M	-$1M
Q1 25	-$1M	-$1M
Q2 25	-$3M	-$3M
Q3 25	-$2M	-$2M
Q4 25	-$2M	-$2M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$0
Q2 23	$5K
Q3 23	$0
Q4 23	$0
Q1 24	$0
Q2 24	$0
Q3 24	$0
Q4 24	$1K
Q1 25	$2K
Q2 25	$3K
Q3 25	$7K
Q4 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	+36.4%
Q2 23	—	+1.0%
Q3 23	—	-22.3%
Q4 23	—	-35.1%
Q1 24	—	-38.7%
Q2 24	—	-24.9%
Q3 24	—	-42.7%
Q4 24	—	-5.6%
Q1 25	—	-15.3%
Q2 25	—	+20.6%
Q3 25	—	+57.5%
Q4 25	—	+51.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$111K	—
Q2 23	$94K	—
Q3 23	$89K	—
Q4 23	$9K	—
Q1 24	$32K	—
Q2 24	$15K	—
Q3 24	$52K	—
Q4 24	$48K	—
Q1 25	$43K	—
Q2 25	$51K	—
Q3 25	$113K	—
Q4 25	$0	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$2M	$1M	—
Q2 23	$1M	$1M	—
Q3 23	$2M	$968K	—
Q4 23	$1M	—	$723K
Q1 24	$1M	$1M	—
Q2 24	$866K	$1M	—
Q3 24	$644K	$946K	—
Q4 24	$985K	—	$689K
Q1 25	$886K	$986K	—
Q2 25	$1M	$1M	—
Q3 25	$1M	—	$1M
Q4 25	$1M	—	$1M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$9M	$0	$9M
Q2 23	$11M	$0	$11M
Q3 23	$8M	$0	$8M
Q4 23	$8M	$0	$8M
Q1 24	$6M	$0	$6M
Q2 24	$5M	$0	$5M
Q3 24	$5M	$0	$5M
Q4 24	$5M	$0	$5M
Q1 25	$13M	$0	$13M
Q2 25	$11M	$0	$11M
Q3 25	$11M	$0	$11M
Q4 25	$21M	$0	$21M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	127K	+0.3%
Q2 23	192K	+51.3%
Q3 23	271K	+41.2%
Q4 23	416K	+53.6%
Q1 24	508K	+22.2%
Q2 24	510K	+0.4%
Q3 24	990K	+94.1%
Q4 24	787K	-20.5%
Q1 25	4M	+447.0%
Q2 25	5M	+11.3%
Q3 25	5M	+14.1%
Q4 25	12M	+112.4%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$5K	15
FY 15	$2K	16
FY 16	$1K	15
FY 17	$1K	15
FY 18	$15K	9
FY 19	$2K	11
FY 20	$0	10
FY 21	$0	12
FY 22	$0	9
FY 23	$0	8
FY 24	$0	5
FY 25	$0	6